Literature DB >> 11096466

Peripheral Arterial Disease.

.   

Abstract

Risk factors for atherosclerosis should be identified and reduced in all patients who have peripheral arterial disease. Cessation of smoking, strict control of diabetes and hypertension, and aggressive reduction in low-density lipoprotein cholesterol level result in a slowdown of disease progression and a reduction in cardiovascular events. Unless contraindicated, all patients with peripheral arterial disease should receive antiplatelet therapy. New pharmacologic therapies are emerging, but supervised exercise rehabilitation is the most effective medical therapy to restore pain-free walking for patients with intermittent claudication. Patients with symptoms that limit their lifestyles may benefit from elective invasive revascularization. Symptoms consistent with limb-threatening ischemia (such as rest pain) or a foot ulcer that does not heal (especially in a patient with diabetes) requires immediate attention and possibly revascularization.

Entities:  

Year:  1999        PMID: 11096466     DOI: 10.1007/s11936-999-0004-x

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  26 in total

1.  Intermittent claudication: its natural course.

Authors:  A M Imparato; G E Kim; T Davidson; J G Crowley
Journal:  Surgery       Date:  1975-12       Impact factor: 3.982

Review 2.  Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review.

Authors:  J I Weitz; J Byrne; G P Clagett; M E Farkouh; J M Porter; D L Sackett; D E Strandness; L M Taylor
Journal:  Circulation       Date:  1996-12-01       Impact factor: 29.690

3.  The effect of postoperative smoking on femoropopliteal bypass grafts.

Authors:  F M Ameli; M Stein; J L Provan; R Prosser
Journal:  Ann Vasc Surg       Date:  1989-01       Impact factor: 1.466

4.  The measured effect of stopping smoking on intermittent claudication.

Authors:  C R Quick; L T Cotton
Journal:  Br J Surg       Date:  1982-06       Impact factor: 6.939

5.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

6.  Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-08

7.  Lipoprotein abnormalities in patients with extra-coronary arteriosclerosis.

Authors:  E Vitale; G Zuliani; L Baroni; L Bicego; F Grego; G Valerio; R Fellin
Journal:  Atherosclerosis       Date:  1990-03       Impact factor: 5.162

8.  Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index.

Authors:  A B Newman; K Sutton-Tyrrell; M T Vogt; L H Kuller
Journal:  JAMA       Date:  1993-07-28       Impact factor: 56.272

9.  Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis.

Authors:  A W Gardner; E T Poehlman
Journal:  JAMA       Date:  1995-09-27       Impact factor: 56.272

10.  Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study.

Authors:  G D Lowe; F G Fowkes; J Dawes; P T Donnan; S E Lennie; E Housley
Journal:  Circulation       Date:  1993-06       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.